Literature DB >> 9222034

Acquired carbapenemases.

D M Livermore1.   

Abstract

Mesh:

Substances:

Year:  1997        PMID: 9222034     DOI: 10.1093/jac/39.6.673

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  17 in total

1.  BetalasEN: microdilution panel for identifying beta-lactamases present in isolates of Enterobacteriaceae.

Authors:  Christine C Sanders; Anton F Ehrhardt; Ellen Smith Moland; Kenneth S Thomson; Barbara Zimmer; Darcie E Roe
Journal:  J Clin Microbiol       Date:  2002-01       Impact factor: 5.948

2.  Expression of SHV-2 beta-lactamase and of reduced amounts of OmpK36 porin in Klebsiella pneumoniae results in increased resistance to cephalosporins and carbapenems.

Authors:  Brendan Crowley; Vicente J Benedí; Antonio Doménech-Sánchez
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

3.  Multidrug-resistant Pathogens: Mechanisms of Resistance and Epidemiology.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

4.  First class a carbapenemase isolated from enterobacteriaceae in Argentina.

Authors:  Marcela Radice; Pablo Power; Gabriel Gutkind; Karina Fernández; Carlos Vay; Angela Famiglietti; Nora Ricover; Juan A Ayala
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

5.  Sensitive EDTA-based microbiological assays for detection of metallo-{beta}-lactamases in nonfermentative gram-negative bacteria.

Authors:  Patricia Marchiaro; María A Mussi; Viviana Ballerini; Fernando Pasteran; Alejandro M Viale; Alejandro J Vila; Adriana S Limansky
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

Review 6.  Meropenem: a review of its use in patients in intensive care.

Authors:  M Hurst; H M Lamb
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

7.  Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing beta-lactamases in Chryseobacterium meningosepticum.

Authors:  S Bellais; D Aubert; T Naas; P Nordmann
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

8.  Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactams.

Authors:  G S Babini; M Yuan; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

9.  Carbapenem derivatives as potential inhibitors of various beta-lactamases, including class B metallo-beta-lactamases.

Authors:  R Nagano; Y Adachi; H Imamura; K Yamada; T Hashizume; H Morishima
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

10.  Carbapenem resistance mediated by beta-lactamases in clinical isolates of Acinetobacter baumannii in Spain.

Authors:  S López-Hernández; T Alarcón; M López-Brea
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.